Series C · AI & Machine Learning · Dublin, Ireland · Founded 2017 · 150–250 employees
Deciphex is an AI-powered digital pathology startup that helps pathologists work up to 40% faster while maintaining diagnostic accuracy. The company offers two main platforms: Diagnexia, which connects global subspecialty pathologists for rapid diagnostics and backlog reduction, and Patholytix, which accelerates drug development through optimized preclinical safety assessments. Backed by major pharmaceutical companies like Novartis and Charles River Laboratories, the company has raised over €70 million in total funding, including a recent €31 million Series C round led by Molten Ventures in January 2025. The startup is addressing a critical healthcare challenge where 70% of medical decisions require pathology investigation, but there's a widening gap between rising patient needs and declining pathologist numbers globally.